Sabatini, M.D., Ph.D., Pasi A.D., Ph.D., Levi A. Garraway, M.D., Ph.D., and Jochen H. Lorch, M.D.: Brief Record: Response and Acquired Level of resistance to Everolimus in Anaplastic Thyroid Cancer A better understanding of the mechanisms of sensitivity and resistance to anticancer therapies may improve individual selection and invite the development of rational treatment designs. One approach involves studying paired biopsy samples of pretreatment and drug-resistant tumors obtained from patients with beautiful sensitivity or unusually long lasting responses to therapy. Tumors that exhibit a dependency on the mTOR pathway might have got enhanced sensitivity to mTOR inhibition.We’ve invested extensively to build up these new technologies and it is important for us to protect these investments by protecting our intellectual real estate.’.
AED Vimpat to be the subject of numerous analyses and studies in AAN meeting Instruction to lacosamide posters for science writers attending the 62nd Annual Conference of the American Academy of NeurologyThe antiepileptic medication Vimpat – would be the subject of numerous studies and analyses-both UCB-sponsored and independent-at the 62nd annual American Academy of Neurology meeting, taking place in the Metro Toronto Convention Center in Toronto from April 10-17. ‘The breadth and depth of Vimpat data getting presented at AAN shows that the neurology community recognizes the essential part of Vimpat in the current epilepsy remedy approach,’ stated James Zackheim, PhD, CNS Medical Director at UCB.